(-)-Salbutamol sulphation in the human liver and duodenal mucosa : interindividual variability

References

• AKAIKE, H., 1976, An information criterion (AIC). Mathematical Science, 14, 5–11.
   Google Scholar
• ANDERSON, R. J. and WEINSHILBOUM, R. M. 1980, Phenolsulphotransferase in human tissues: radio-chemical enzymatic assay and biochemical properties. Clinica Chimica Acta, 193, 79–90.
   Google Scholar
• BRITTAIN, R. T., FARMER, J. B. and MARSHAL, R. J., 1973, Some observations on the fl-adrenoceptor agonists properties of the isomers of salbutamol. British Journal of Pharmacology, 48, 144–147.
   PubMed Web of Science ®Google Scholar
• CAMPBELL, N. R. C., VAN L OON, J. A and WEINSHILBOUM, R. C., 1987, Human liver phenol sulpho-transferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochemical Pharmacology, 36, 1435–1446.
   Google Scholar
• CAPPIELLO M GIULLkNI, L. and PACIHCI, G. M., 1990, Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa. Pharmacology, 40, 69–76.
   Google Scholar
• DEMNATI, R., M ICHOUD M C., JEANNERET - GROSJEAN, A., ONG, H. and SOUICH, P., 1995, Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis. British Journal of Clinical Pharmacology, 40, 319–324.
   Google Scholar
• FALANY, C. N., 1991, Molecular enzymology of human liver cytosolic sulphotransferases. Trends in Pharmacological Sciences, 12, 255–259.
   PubMed Web of Science ®Google Scholar
• FOLDES, A. and MK, J. K., 1973, Rat brain phenol sulphotransferase partial purification and some properties. Biochimica et Biophysica Acta, 327, 365–374.
   PubMed Web of Science ®Google Scholar
• FORBES - B AMFORTH, K. J. and C OUGHTRIE M. W. H., 1994, Identification of a new adult liver sulphotransferase with specificity for endogenous and xenobiotic estrogens. Endocrinology 198, 707–711.
   Google Scholar
• HERNANDEZ, J. S., WATSON, W. G., WOOD, T. S. and WEINSHILBOUM, R. M., 1992, Sulphation of oestrone and 17J3-oestradiol in human liver. Catalysis by thermostable phenol sulphotransferase and by dehydroepiandro sterone sulphotransferase. Drug Metabolism and Disposition, 20, 413–422.
   PubMed Web of Science ®Google Scholar
• HAUKKAMAA, M G UM MERUS M. and KLEIMOLA, T., 1985, Serum salbutamol concentrations during oral and intravenous treatment in pregnant women. British Journal of Obstetrics and Gynaecology, 92, 1230–1233.
   Google Scholar
• HUTCHINGS, M. J., PAULL, J. D., WILSON -EVERED, E. and M ORGAN, D. J., 1987, Pharmacokinetics and metabolism of salbutamol in premature labor. British Journal of Clinical Pharmacology, 24, 69–75.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MORGAN, D. J., 1990, Clinical pharmacokinetics of fl-agonists. Clinical Pharmacokinetics, 18, 270–294.
   PubMed Web of Science ®Google Scholar
• MENTRE, F. and G OMENI, R., 1995, A two-step iterative algorithm for estimation in non-linear mixed- effect models with an evaluation in population pharmacokinetics. Journal of Pharmacokinetics and Statistics, 5, 141–148.
   Google Scholar
• MORGAN, D. J., and PAULL, J. D., RICHMOND, B. H., WILSON -EVERED, E. and ZICCONE, S. P., 1986, Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. British Journal of Clinical Pharmacology, 22, 587–593.
   Google Scholar
• PAC1FICI, G. M. and DE'S ANTI, C., 1995, Human sulphotransfera se. Classification and metabolic profile of the major isoforms. The point of view of the clinical Pharmacologist. In Advances in Drug Metabolism in Man edited by G. M. Pacifici and G. N. Fracchia (Luxembourg /Brussels : EC), pp. 311–349.
   Google Scholar
• PAC1FICI, G. M., BIGOTTI, R., MARCHI, G. and GIULIANI, L., 1993, Minoxidil sulphation in human liver and platelets. A study of interindividual variability. European Journal of Clinical Pharmacology, 45, 337–341.
   Google Scholar
• PAC1FICI, G. M., DE'S ANTI, C., Muss', A. and ANGELETTI, C., 1996, Interindividual variability in the rate of salbutamol sulphation in the human lung. European Journal of Clinical Pharmacology, 49, 299–303.
   Google Scholar
• PAC1FICI, G. M., TEMELLINI, A., CASTIGLIONI, M., D'ALESSANDRO, C., Ducci, A. and GIULIANI, L., 1994, Interindividual variability of the human hepatic sulphotransfera ses. Chemical-Biological Interactions, 92, 219–231.
   Google Scholar
• PESOLA, G. R. and W ALLE T., 1992, Enantiomeric interaction in the sulphate conjugation of the )32-agonist drug albuterol by the human liver. Research Communications in Chemical Pathology and Pharmacology, 75, 125–128.
   Google Scholar
• POND, S. M. and T OZER, T. N. 1984, First-pass elimination basic concepts and clinical consequences. Clinical Pharmacokinetics, 9, 1–25.
   PubMed Web of Science ®Google Scholar
• REYNOLDS, E. F., 1993, Martindale: The Extra Pharmacopeia, 13th edn (London: Pharmaceutical Press), pp. 1255–1257.
   Google Scholar
• SUNDARAM, R. S., SZUMLANSKI, C., O TTERNESS, D., VAN LOON, J. A. and WEINSHILBOUM, R. M., 1989, Human intestinal phenol sulphotransferase : assay conditions, activity levels and partial purifica-tion of the thermolable form. Drug Metabolism and Disposition, 17, 255–264.
   PubMed Web of Science ®Google Scholar
• TAN, Y. K. and SOLDIN, S. J., 1987, Analysis of salbutamol enantiomers in human urine by chiral high-performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man. Journal of Chromatography, 422, 187–195.
   PubMed Web of Science ®Google Scholar
• WALKER, S. R., EVANS, M. E. and RICHARDS, A. J., 1972, The clinical Pharmacology of oral and inhaled salbutamol. Clinical Pharmacology and Therapeutics, 13, 861–967.
   PubMed Web of Science ®Google Scholar
• WALLE U. K., PESOLA, G. R. and W ALLE, T., 1993, Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. British Journal of Clinical Pharmacology, 35, 413–418.
   Google Scholar